<?xml version="1.0" encoding="UTF-8"?>
<p id="p0125">Though these reports provide some preliminary data suggesting benefit of convalescent plasma, conclusions should be drawn with caution as these reports share the same limitations as summarized in 
 <xref rid="t0010" ref-type="table">Table 2</xref> . Most of these limitations also apply to the majority of published reports on the use of convalescent plasma in the treatment of viral infections. The pervasiveness of such limitations in the literature points to the necessity for large scale, multi-center randomized controlled clinical trials.
</p>
